Brief: VBI Vaccines Reports First Quarter 2022 Financial Results
09/05/2022 13:32
May 9 (Reuters) - VBI Vaccines Inc VBIV.O :
* VBI VACCINES REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES CORPORATE UPDATE
* Q1 REVENUE $100,000
* Q1 LOSS PER SHARE $0.08
* $101.3 MILLION IN CASH AT END OF Q1 2022
Source text for Eikon: ID:nBw7LZJNGa
Further company coverage: VBIV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VBI Vaccines
See all newsBrief: VBI Vaccines Provides Update On Its Restructuring Proceedings
Brief: Vbi Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2B Study Of Vbi-1901 In Recurrent Glioblastoma Patients
VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary
Brief: VBI Vaccines Says Entered At Market Offering Deal For Gross Proceeds Of Up To $8.5 Mln
Brief: VBI Vaccines Q1 Adjusted EPS USD -0.55